Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
Holding SOPH?
Track your performance easily
SOPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.33 - $7.37
Previous Close$3.99
Volume22.47K
Average Volume (3M)67.73K
Market Cap
$260.85M
Enterprise Value$142.66M
Total Cash (Recent Filing)$121.12M
Total Debt (Recent Filing)$2.93M
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Nov 05, 2024EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.02
Shares Outstanding65,230,559
10 Day Avg. Volume43,262
30 Day Avg. Volume67,734
Standard Deviation0.24
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.72
Price to Sales (P/S)4.08
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.12
Enterprise Value/Gross Profit3.32
Enterprise Value/Ebitda-3.18
Forecast
1Y Price Target
$6.00Price Target Upside50.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
SOPHiA GENETICS News
PremiumCompany Announcements
SOPHiA GENETICS Reports Mid-Year Financials
Bulls Say, Bears Say
Bulls Say
Business ModelAn inherently higher margin business model and a healthy balance sheet should provide downside support, particularly given the undemanding valuation.
Management OutlookManagement believes current headwinds are transitory, and the underlying drivers such as new customer additions, pharma pipeline, and utilization trends all remain positive.
ProfitabilityManagement reiterated confidence in achieving operating profitability in the next two years.
Bears Say
GuidanceManagement lowered FY'24 guidance by approximately 17%, primarily due to weaker performance expected in the second half.
Market ConditionsRevenue in the quarter was negatively impacted by macro-related headwinds in the Biopharma end market and in EMEA.
Revenue2Q revenue of $15.8M fell short of expectations, missing consensus estimates of $17.4M.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
2.67% Mutual Funds
20.56% Other Institutional Investors
76.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by SOPHiA GENETICS
Desktop Users
Mobile Users
SOPH FAQ
What was SOPHiA GENETICS’s price range in the past 12 months?
SOPHiA GENETICS lowest stock price was $2.33 and its highest was $7.37 in the past 12 months.
What is SOPHiA GENETICS’s market cap?
Currently, no data Available
When is SOPHiA GENETICS’s upcoming earnings report date?
SOPHiA GENETICS’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were SOPHiA GENETICS’s earnings last quarter?
SOPHiA GENETICS released its earnings results on Aug 06, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.266 by $0.036.
Is SOPHiA GENETICS overvalued?
According to Wall Street analysts SOPHiA GENETICS’s price is currently Undervalued.
Does SOPHiA GENETICS pay dividends?
SOPHiA GENETICS does not currently pay dividends.
What is SOPHiA GENETICS’s EPS estimate?
SOPHiA GENETICS’s EPS estimate is -$0.22.
How many shares outstanding does SOPHiA GENETICS have?
SOPHiA GENETICS has 65,375,090 shares outstanding.
What happened to SOPHiA GENETICS’s price movement after its last earnings report?
SOPHiA GENETICS reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.266. Following the earnings report the stock price went down -2.169%.
Which hedge fund is a major shareholder of SOPHiA GENETICS?
Among the largest hedge funds holding SOPHiA GENETICS’s share is Generation Investment Management LLP. It holds SOPHiA GENETICS’s shares valued at 31M.
---
SOPHiA GENETICS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (50.75% Upside)
$6.00 (50.75% Upside)
Blogger Sentiment
Neutral
SOPH Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.9M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
65.56%
12-Months-Change
Fundamentals
Return on Equity
-45.56%
Trailing 12-Months
Asset Growth
-18.86%
Trailing 12-Months
Company Description
SOPHiA GENETICS
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.
---
SOPH Company Deck
---
SOPH Earnings Call
Q2 2024
0:00 / 0:00
---
SOPH Stock 12 Month Forecast
Average Price Target
$6.00
▲(50.75% Upside)
Technical Analysis
Best Analysts Covering SOPH
1 Year
1 Year Success Rate
6/9 ratings generated profit
1 Year Average Return
+22.84%
reiterated a buy rating last month
Copying Mark Massaro's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +22.84% per trade.
---